Description: Aurisco Pharmaceutical Co.,Ltd. engages in research, manufacturing, and marketing of intermediates, specialty active pharmaceutical ingredients (API's), and formulations catering to the pharmaceutical market worldwide. The company offers steroids, oncology, antiretroviral, and other APIs and intermediates. It also provides contract manufacturing services and related development works for chemicals, intermediates, and API's. Aurisco Pharmaceutical Co.,Ltd. was founded in 1998 and is headquartered in Tiantai, China.
Home Page: www.aurisco.com
Badu Industrial Park Zone
Tiantai,
317200
China
Phone:
86 21 5298 7136
Officers
| Name | Title |
|---|---|
| Dingjun Chu | Director and Gen. Mang. |
Exchange: SHG
Country: CN
Currency: Renminbi (¥)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 46.5345 |
| Price-to-Book MRQ: | 6.443 |
| Price-to-Sales TTM: | 11.1006 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 939 |